During the ‘What you should not have missed’ session at this year’s BSMO meeting, Prof. Dr. Awada from the Jules Bordet Institute revisited key treatment advances and clinical updates in oncology from 2023.
By: A. Enguita PhD
During the ‘What you should not have missed’ session at this year’s BSMO meeting, Prof. Dr. Awada from the Jules Bordet Institute revisited key treatment advances and clinical updates in oncology from 2023.
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
